Browse by topic
Subscribe to our blog

COVID-19: Impact on medication adherence in 2020

2020 was dominated by the COVID-19 pandemic, and it will continue to dominate healthcare conversations this year. Looking back, how did the pandemic affect medication adherence? And what lessons were learned? Patient concerns about ability to pay
Read

Specialty drugs: the challenge of therapy initiation

AllazoHealth’s VP, Business Development Dev Mukherjee recently answered questions about specialty medications and the challenges faced by pharmaceutical companies and specialty drug pharmacies in regards to therapy initiation. What challenges do ...
Read

“Adherence Intelligence” is the new AI

How recognizing the unique characteristics of each patient optimizes resources and maximizes impact Medication non-adherence is an age-old problem that pharmaceutical companies have been grappling with for decades. According to industry ...
Read

DIR contracts: How to prioritize for maximum value

AllazoHealth’s William Grambley, Chief Operating Officer, and Dr. Linda Schultz, VP, Clinical and Customer Success, address the factors that pharmacies should consider when prioritizing their DIR contracts. Their discussion includes how to evaluate ...
Read

Patient intervention: Effective tactics for pharmacies, payers and pharma

When it comes to patient intervention programs to promote adherence, what are the best tactics? The right answer may be “all of them” – but it also depends on who is setting up the program. Pharmacies, payers, or pharmaceutical companies often have ...
Read

Two recent studies show smart pill bottles have positive impact

Small study demonstrates smart pill bottles can improve adherence interventions for cancer patients A smart pill bottle platform improved adherence and patient satisfaction among a small sample of multiple myeloma patients, according to a paper in ...
Read